iFAST Diagnostics
Healthcare & Life Sciences
Recent Finacing
Seed
Recent Raise
$6.4M
iFAST Diagnostics develops high-throughput antimicrobial susceptibility testing technology using microchip technology to rapidly analyze bacterial samples and combat antimicrobial resistance.
Focus Areas
Antimicrobial susceptibility testing
microchip technology
bacterial analysis
antibiotic treatment
healthcare resilience.
Investors
